Buclizine D8 Dihydrochloride
| Product Name | Buclizine D8 Dihydrochloride |
|---|---|
| Alternate Names | Buclizine Stable Isotopes, Stable Isotopes of Buclizine |
| CAT No. | CS-O-06448 |
| CAS No. | 129-74-8(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 514.00 g/mol |
| Mol. For. | C₂₈H₂₇D₈Cl₃N₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Buclizine |
| Purity | 99.86 |
| Therapeutic | Antihistamine |
| Smileys | ClC1=CC=C(C=C1)C(C2=CC=CC=C2)N3C([2H])([2H])C([2H])([2H])N(CC4=CC=C(C(C)(C)C)C=C4)C([2H])([2H])C3([2H])[2H].Cl.Cl |
| Canonical Smiles | CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl.Cl |
| InchIKey | SDBHDSZKNVDKNU-UHFFFAOYSA-N |
| Inchl | InChI=1S/C28H33ClN2.2ClH/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24;;/h4-16,27H,17-21H2,1-3H3;2*1H |
| IUPAC | 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Buclizine D8 Dihydrochloride is a medication that is commonly used to treat motion sickness. It works by blocking the histamine receptors in the brain, which are responsible for causing the symptoms of motion sickness. This medication is often used to treat nausea, vomiting, and dizziness that can occur during travel or other activities that involve motion.
Chemically speaking, Buclizine D8 Dihydrochloride is a derivative of the antihistamine medication, cyclizine. It is a white, crystalline powder that is soluble in water and alcohol. The chemical formula for Buclizine D8 Dihydrochloride is C14H22ClN3O•2HCl, and its molecular weight is 406.27 g/mol.
The recommended dosage of Buclizine D8 Dihydrochloride varies depending on the individual and the severity of their symptoms. It is typically taken orally, either with or without food, and the dosage should be adjusted based on the patient's response to treatment. This medication is generally well-tolerated, although some patients may experience side effects such as drowsiness, dry mouth, and blurred vision.
Overall, Buclizine D8 Dihydrochloride is an effective medication for treating motion sickness and related symptoms. Its chemical properties and mechanism of action make it a valuable tool in managing this common condition.
Get an Instant Quote
Related Compounds
Buclizine 13C6 |